BIOMARIN PHARMACEUTICAL INC Quarterly Common Stock, Shares, Outstanding from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Biomarin Pharmaceutical Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2010 to Q2 2024.
  • Biomarin Pharmaceutical Inc Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 190M shares, a 1.17% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 190M +2.2M +1.17% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 190M +2.18M +1.16% Mar 31, 2024 10-Q 2024-04-26
Q4 2023 189M +2.35M +1.26% Dec 31, 2023 10-Q 2024-08-05
Q3 2023 188M +2.52M +1.35% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 188M +2.7M +1.46% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 188M +2.7M +1.46% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 186M +2.34M +1.27% Dec 31, 2022 10-K 2024-02-26
Q3 2022 186M +2.26M +1.23% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 185M +2.13M +1.16% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 185M +2.23M +1.22% Mar 31, 2022 10-Q 2022-04-29
Q4 2021 184M +2.17M +1.2% Dec 31, 2021 10-K 2023-02-27
Q3 2021 184M +2.08M +1.14% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 183M +2.17M +1.2% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 183M +1.91M +1.06% Mar 31, 2021 10-Q 2021-04-30
Q4 2020 182M +1.9M +1.06% Dec 31, 2020 10-K 2022-02-25
Q3 2020 181M +1.89M +1.05% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 181M +1.72M +0.96% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 181M +1.73M +0.97% Mar 31, 2020 10-Q 2020-05-01
Q4 2019 180M +1.59M +0.89% Dec 31, 2019 10-K 2021-02-26
Q3 2019 180M +1.7M +0.96% Sep 30, 2019 10-Q/A 2019-11-04
Q2 2019 179M +1.93M +1.09% Jun 30, 2019 10-Q 2019-08-02
Q1 2019 179M +2.38M +1.35% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 178M +2.41M +1.37% Dec 31, 2018 10-K 2020-02-27
Q3 2018 178M +2.41M +1.37% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 178M +2.26M +1.29% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 177M +3.35M +1.93% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 176M +3.2M +1.85% Dec 31, 2017 10-K 2019-02-28
Q3 2017 175M +3.8M +2.21% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 175M +12M +7.33% Jun 30, 2017 10-Q 2017-08-02
Q1 2017 173M +11.1M +6.82% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 173M +11.1M +6.89% Dec 31, 2016 10-K 2018-02-26
Q3 2016 172M +10.5M +6.5% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 163M +2.27M +1.41% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 162M +1.96M +1.22% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 162M +12.4M +8.34% Dec 31, 2015 10-K 2017-02-27
Q3 2015 161M +13.8M +9.36% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 161M +13.9M +9.48% Jun 30, 2015 10-Q 2015-08-05
Q1 2015 160M +14.5M +9.98% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 149M +5.63M +3.92% Dec 31, 2014 10-K 2016-02-29
Q3 2014 147M +5.23M +3.68% Sep 30, 2014 10-Q 2014-10-28
Q2 2014 147M +7.02M +5.01% Jun 30, 2014 10-Q 2014-07-31
Q1 2014 146M +6.87M +4.94% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 143M +17.7M +14% Dec 31, 2013 10-K 2015-03-02
Q3 2013 142M +18.4M +14.9% Sep 30, 2013 10-Q 2013-10-28
Q2 2013 140M +16.8M +13.6% Jun 30, 2013 10-Q 2013-07-29
Q1 2013 139M +23.2M +20% Mar 31, 2013 10-Q 2013-04-29
Q4 2012 126M +11M +9.6% Dec 31, 2012 10-K 2014-02-26
Q3 2012 124M +9.64M +8.45% Sep 30, 2012 10-Q 2012-10-29
Q2 2012 123M +11.7M +10.5% Jun 30, 2012 10-Q 2012-08-02
Q1 2012 116M +4.81M +4.34% Mar 31, 2012 10-Q 2012-04-30
Q4 2011 115M +4.16M +3.76% Dec 31, 2011 10-K 2013-02-26
Q3 2011 114M +11.7M +11.4% Sep 30, 2011 10-Q 2011-10-31
Q2 2011 112M +9.55M +9.36% Jun 30, 2011 10-Q 2011-08-01
Q1 2011 111M Mar 31, 2011 10-Q 2011-04-29
Q4 2010 111M Dec 31, 2010 10-K 2012-02-22
Q3 2010 102M Sep 30, 2010 10-Q 2010-10-29
Q2 2010 102M Jun 30, 2010 10-Q 2010-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.